Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Arcutis Biotherapeutics, Inc."
Count: 22
Selected: 0
NCT IDTitle
NCT04655313Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)
NCT04845620Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
NCT04804605Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
NCT04773600Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
NCT04773587Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
NCT04378569Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema
NCT04973228Trial of PDE4 Inhibition With Roflumilast for the Management of Seborrheic Dermatitis (STRATUM)
NCT04211389Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
NCT04156191Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema
NCT04445987Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
NCT03638258The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
NCT05028582Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
NCT04286607Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
NCT04211363Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
NCT03764475Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
NCT04811131Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo
NCT04746911Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)
NCT04128007Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
NCT04091646Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
NCT03392168Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
NCT04279119Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis
NCT03916081Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis